Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

262 trials with published results (19%)

Research Maturity

755 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.4%

86 terminated out of 1349 trials

Success Rate

89.8%

+3.2% vs benchmark

Late-Stage Pipeline

18%

249 trials in Phase 3/4

Results Transparency

35%

262 of 755 completed with results

Key Signals

262 with results90% success86 terminated

Data Visualizations

Phase Distribution

938Total
Not Applicable (446)
Early P 1 (14)
P 1 (111)
P 2 (118)
P 3 (158)
P 4 (91)

Trial Status

Completed755
Recruiting177
Unknown173
Terminated86
Not Yet Recruiting53
Withdrawn39

Trial Success Rate

89.8%

Benchmark: 86.5%

Based on 755 completed trials

Clinical Trials (1349)

Showing 20 of 20 trials
NCT07563881Phase 3Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

NCT06352372Phase 2Completed

Safety and Efficacy of tPBM for Epileptiform Activity in Autism

NCT06546410CompletedPrimary

OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS

NCT07735715Not ApplicableNot Yet RecruitingPrimary

HOBSCOTCH-YOUTH and Young Adults

NCT06623994Not ApplicableRecruitingPrimary

Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)

NCT02531880Phase 1RecruitingPrimary

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

NCT02107989RecruitingPrimary

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

NCT01273129RecruitingPrimary

Surgery as a Treatment for Medically Intractable Epilepsy

NCT05954182Not ApplicableActive Not RecruitingPrimary

Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)

NCT06135285Not ApplicableNot Yet RecruitingPrimary

A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position

NCT04715646Phase 3RecruitingPrimary

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

NCT07572812Phase 1Not Yet RecruitingPrimary

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

NCT07721272Early Phase 1Not Yet RecruitingPrimary

Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation

NCT07520955Not ApplicableNot Yet RecruitingPrimary

Lily's Grace Temporal Interference

NCT07723287SuspendedPrimary

Risk Factors for Drug-Resistant Epilepsy in Children

NCT07717632Not ApplicableActive Not RecruitingPrimary

AI-enhanced LF-MRI in Epilepsy

NCT04526093Recruiting

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

NCT07594119Phase 3Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

NCT07147309RecruitingPrimary

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

NCT07716930Enrolling By Invitation

Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy

Scroll to load more

Research Network

Activity Timeline